⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNYA News
Tenaya Therapeutics, Inc. Common Stock
Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight
prnewswire.com
LXEO
TNYA
RPTX
Tenaya Therapeutics Announces Pricing of Public Offering
globenewswire.com
TNYA
Tenaya Therapeutics Announces Proposed Public Offering
globenewswire.com
TNYA
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
globenewswire.com
TNYA
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
globenewswire.com
TNYA
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
TNYA
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
globenewswire.com
TNYA
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
globenewswire.com
TNYA
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
globenewswire.com
TNYA
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
globenewswire.com
TNYA